Sunday, 31 Jan 2021 12:22 PM MYT
BY JERRY CHOONG
Minister of Health Datuk Seri Dr Adham Baba denies that Mestron has been issued any clearance for any vaccine distribution deal. Picture by Miera Zulyana
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, Jan 31 Local holding company Mestron Holdings Berhad is being investigated by the Ministry of Health for alleging it has been granted approval to go ahead with a Covid-19 vaccine distribution deal.
Malaysiakini reported its minister Datuk Seri Dr Adham Baba as denying such approval had been given, adding that Mestron has never been issued any clearance letter to do so.
KUALA LUMPUR, Jan 31 Mestron Holding Bhd clarified today that it has not been given any official clearance to purchase or distribute Covid-19 vaccines in Malaysia. Yesterday, Health Minister Datuk Seri Dr Adham Baba reportedly said the firm would be investigated for purporting to have received.
Saturday, 30 Jan 2021 05:26 PM MYT
Mestron is currently negotiating a collaboration with a China company on vaccine distribution. Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, Jan 30 Mestron Holdings Bhd today reiterated the company had obtained a clearance letter from the Ministry of Health (MOH) to commence negotiation and cooperation with any companies from China in relation to the Covid-19 vaccine distribution in Malaysia.
In a statement, Mestron said the letter dated Jan 8, 2021 allowed the company to discuss and collaborate on the importation, distribution, sale, marketing, use, and application of the Covid-19 vaccine in the country.
KUALA LUMPUR (Jan 29): Mestron Holdings Bhd is the latest company to propose venturing into the Covid-19 vaccine distribution business.
The steel pole maker said it has inked a Heads of Agreement (HOA) with China-based Zhongyu Yexing (Chengdu) Industrial Co Ltd to distribute the Covid-19 vaccine in Malaysia.
In a statement, Mestron said it expects to invest up to RM20 million for this business venture, which will be funded via internally-generated funds, bank loans and proceeds from a private placement.
Zhongyu is part of the Sino Pharma Group of Companies, and is one of the authorised distributors for Sinopharm’s China National Biotech Group Covid-19 vaccine.